Expressions of IL-18,IL-12 and IFN-γ in Chronic Severe Hepatitis Patients and Treatment with Artificial Liver Support System

李天一,叶卫江,张松平,吴国琳
DOI: https://doi.org/10.3969/j.issn.0253-3685.2008.05.003
2008-01-01
Abstract:Objective To investigate the expressions of serum interleukin(IL)-18,IL-12 and interferon factor(IFN)-γ in patients with chronic severe hepatitis (CSH) and the effect of treatment interferon factor artificial liver support system(ALSS) on them.Methods Serum IL-18,IL-12 and IFN-γ levels were determined by ELISA method in 148 CSH cases and 20 healthy people.ALT,TBil and PTA were determined before and after ALSS treatment.Complications were observed. Results Serum IL-18,IL-12 and IFN-γ levels in CSH were significantly higher than those in the healthy controls(P0.01).The expressions of IL-18,IL-12 and IFN-γ after ALSS treatment were (778.3±320.1),(614.9±264.9) and (325.7±153.5)pg/ml,which were significantly lower than (819.1±334.3),(661.9±284.9) and (341.9±152.2)pg/ml before (P0.01).There was a close positive correlation between IL-18 and IL-12,IFN-γ.ALSS treatment had obvious effect in the increase of PTA and recovery of liver function and hepatic coma.Conclusion IL-18,IL-12 and IFN-γ may participate in liver inflammatory injury prosess and have relevence with CSH. ALSS treatment can effectively decrease serum IL-18,IL-12 and IFN-γ level.
What problem does this paper attempt to address?